Literature DB >> 19084936

Transjugular intrahepatic portosystemic shunt-placement increases arginine/asymmetric dimethylarginine ratio in cirrhotic patients.

Michiel P C Siroen1, Reiner Wiest, Milan C Richir, Tom Teerlink, Jan A Rauwerda, Friedrich T Drescher, Niels Zorger, Paul A M van Leeuwen.   

Abstract

AIM: To analyze the change of dimethylarginine plasma levels in cirrhotic patients receiving transjugular intrahepatic portosystemic shunt (TIPS).
METHODS: To determine arginine, asymmetric dimethylarginine (ADMA), symmetric dimethylarginine (SDMA), and nitric oxide (NO) plasma levels, blood samples were collected from the superior cava, hepatic, and portal vein just before, directly after, and 3 mo after TIPS-placement.
RESULTS: A significant increase in the arginine/ADMA ratio after TIPS placement was shown. Moreover, TIPS placement enhanced renal function and thereby decreased systemic SDMA levels. In patients with renal dysfunction before TIPS placement, both the arginine/ADMA ratio and creatinine clearance rate increased significantly, while this was not the case in patients with normal renal function before TIPS placement. Hepatic function did not change significantly after TIPS placement and no significant decline in ADMA plasma levels was measured.
CONCLUSION: The increase of the arginine/ADMA ratio after TIPS placement suggests an increase in intracellular NO bioavailability. In addition, this study suggests that TIPS placement does not alter dimethylarginine dimethylaminohydrolase (DDAH) activity and confirms the major role of the liver as an ADMA clearing organ.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19084936      PMCID: PMC2776879          DOI: 10.3748/wjg.14.7214

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  28 in total

1.  The puzzle of endothelial nitric oxide synthase dysfunction in portal hypertension: The missing piece?

Authors:  Rajeshwar P Mookerjee; Balasubramaniyan Vairappan; Rajiv Jalan
Journal:  Hepatology       Date:  2007-09       Impact factor: 17.425

2.  The human liver clears both asymmetric and symmetric dimethylarginine.

Authors:  Michiel P C Siroen; Joost R M van der Sijp; Tom Teerlink; Cors van Schaik; Robert J Nijveldt; Paul A M van Leeuwen
Journal:  Hepatology       Date:  2005-03       Impact factor: 17.425

3.  Accumulation of symmetric dimethylarginine in hepatorenal syndrome.

Authors:  Paloma Lluch; Maria D Mauricio; José M Vila; Gloria Segarra; Pascual Medina; Juan A Del Olmo; José M Rodrigo; Miguel A Serra
Journal:  Exp Biol Med (Maywood)       Date:  2006-01

4.  The transplanted liver graft is capable of clearing asymmetric dimethylarginine.

Authors:  Michiel P C Siroen; Michiel C Warlé; Tom Teerlink; Robert J Nijveldt; Ernst J Kuipers; Herold J Metselaar; Hugo W Tilanus; Dirk J Kuik; Joost R M van der Sijp; Sybren Meijer; Ben van der Hoven; Paul A M van Leeuwen
Journal:  Liver Transpl       Date:  2004-12       Impact factor: 5.799

5.  Plasma concentrations of nitric oxide and asymmetric dimethylarginine in human alcoholic cirrhosis.

Authors:  Paloma Lluch; Belén Torondel; Pascual Medina; Gloria Segarra; Juan A Del Olmo; Miguel A Serra; José M Rodrigo
Journal:  J Hepatol       Date:  2004-07       Impact factor: 25.083

6.  Cardiovascular effects of systemic nitric oxide synthase inhibition with asymmetrical dimethylarginine in humans.

Authors:  Jan T Kielstein; Burcu Impraim; Solveig Simmel; Stefanie M Bode-Böger; Dimitrios Tsikas; Jürgen C Frölich; Marius M Hoeper; Hermann Haller; Danilo Fliser
Journal:  Circulation       Date:  2003-12-08       Impact factor: 29.690

7.  Endogenous dimethylarginine as an inhibitor of nitric oxide synthesis.

Authors:  P Vallance; A Leone; A Calver; J Collier; S Moncada
Journal:  J Cardiovasc Pharmacol       Date:  1992       Impact factor: 3.105

8.  Detection of NG,NG-dimethylarginine dimethylaminohydrolase in the nitric oxide-generating systems of rats using monoclonal antibody.

Authors:  M Kimoto; H Tsuji; T Ogawa; K Sasaoka
Journal:  Arch Biochem Biophys       Date:  1993-02-01       Impact factor: 4.013

9.  The asymmetrical dimethylarginine (ADMA)-multiple organ failure hypothesis.

Authors:  R J Nijveldt; T Teerlink; P A M van Leeuwen
Journal:  Clin Nutr       Date:  2003-02       Impact factor: 7.324

10.  Asymmetrical dimethylarginine (ADMA) in critically ill patients: high plasma ADMA concentration is an independent risk factor of ICU mortality.

Authors:  R J Nijveldt; T Teerlink; B Van Der Hoven; M P C Siroen; D J Kuik; J A Rauwerda; P A M van Leeuwen
Journal:  Clin Nutr       Date:  2003-02       Impact factor: 7.324

View more
  9 in total

Review 1.  Endothelial dysfunction in cirrhosis: Role of inflammation and oxidative stress.

Authors:  Balasubramaniyan Vairappan
Journal:  World J Hepatol       Date:  2015-03-27

2.  Estimation of Glomerular Filtration Rate in Patients With Cirrhosis by Using New and Conventional Filtration Markers and Dimethylarginines.

Authors:  Ayse L Mindikoglu; Thomas C Dowling; Laurence S Magder; Robert H Christenson; Matthew R Weir; Stephen L Seliger; William R Hutson; Charles D Howell
Journal:  Clin Gastroenterol Hepatol       Date:  2015-06-29       Impact factor: 11.382

Review 3.  New Developments in Hepatorenal Syndrome.

Authors:  Ayse L Mindikoglu; Stephen C Pappas
Journal:  Clin Gastroenterol Hepatol       Date:  2017-06-07       Impact factor: 11.382

4.  Asymmetric dimethylarginine is strongly associated with cognitive dysfunction and brain MR spectroscopic abnormalities in cirrhosis.

Authors:  Jasmohan S Bajaj; Vishwadeep Ahluwalia; James B Wade; Arun J Sanyal; Melanie B White; Nicole A Noble; Pamela Monteith; Michael Fuchs; Richard K Sterling; Velimir Luketic; Iliana Bouneva; Richard T Stravitz; Puneet Puri; Kenneth A Kraft; Hochong Gilles; Douglas M Heuman
Journal:  J Hepatol       Date:  2012-08-11       Impact factor: 25.083

Review 5.  Current concepts in the diagnosis and classification of renal dysfunction in cirrhosis.

Authors:  Ayse L Mindikoglu; Matthew R Weir
Journal:  Am J Nephrol       Date:  2013-10-05       Impact factor: 3.754

6.  The transhepatic endotoxin gradient is present despite liver cirrhosis and is attenuated after transjugular portosystemic shunt (TIPS).

Authors:  Daniel Benten; Julian Schulze zur Wiesch; Karsten Sydow; Andreas Koops; Peter Buggisch; Rainer H Böger; Charlotte A Gaydos; Helen Won; Veronica Franco; Ansgar W Lohse; Stuart C Ray; Ashwin Balagopal
Journal:  BMC Gastroenterol       Date:  2011-10-06       Impact factor: 3.067

Review 7.  Increased circulatory asymmetric dimethylarginine and multiple organ failure: bile duct ligation in rat as a model.

Authors:  Jiunn-Ming Sheen; Yu-Chieh Chen; You-Lin Tain; Li-Tung Huang
Journal:  Int J Mol Sci       Date:  2014-03-05       Impact factor: 5.923

Review 8.  Asymmetric Dimethylarginine and Hepatic Encephalopathy: Cause, Effect or Association?

Authors:  Anna Czarnecka; Krzysztof Milewski; Magdalena Zielińska
Journal:  Neurochem Res       Date:  2016-11-25       Impact factor: 3.996

9.  Association of Asymmetric Dimethylarginine and Nitric Oxide with Cardiovascular Risk in Patients with End-Stage Liver Disease.

Authors:  Maro Dragičević; Iva Košuta; Egon Kruezi; Marijana Vučić Lovrenčić; Anna Mrzljak
Journal:  Medicina (Kaunas)       Date:  2020-11-18       Impact factor: 2.430

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.